Featured Product
This Week in Quality Digest Live
Health Care Features
Etienne Nichols
How to give yourself a little more space when things happen
Chris Bush
Penalties for noncompliance can be steep, so it’s essential to understand what’s required
Jennifer Chu
Findings point to faster way to find bacteria in food, water, and clinical samples
Smaller, less expensive, and portable MRI systems promise to expand healthcare delivery
Lindsey Walker
A CMMS provides better asset management, streamlined risk assessments, and improved emergency preparedness

More Features

Health Care News
Showcasing the latest in digital transformation for validation professionals in life sciences
An expansion of its medical-device cybersecurity solution as independent services to all health systems
Purchase combines goals and complementary capabilities
Better compliance, outbreak forecasting, and prediction of pathogens such as listeria or salmonella
Links ZEISS research and capabilities in automated, high-resolution 3D imaging and analysis
Creates one of the most comprehensive regulatory SaaS platforms for the industry
Resistant to high-pressure environments, and their 3/8-in. diameter size fits tight spaces
Easy, reliable leak testing with methylene blue
New medical product from Canon’s Video Sensing Division

More News

Washington University

Health Care

Seeing Melanoma

New technique creates 3-D views of the deadliest skin cancer

Published: Tuesday, August 24, 2010 - 05:30

Melanoma is one of the less common types of skin cancer, but it accounts for the majority of skin cancer deaths (about 75%). The five-year survival rate for early-stage melanoma is high (98%), but the rate drops precipitously if the cancer is detected late or there is recurrence.

So a great deal rides on the accuracy of initial surgery, where the goal is to remove as little tissue as possible while obtaining “clean margins” all around the tumor.

Up till now, no imaging technique has been up to the task of resolving the melanoma accurately enough to guide surgery. Instead, surgeons tend to cut well beyond the visible margins of the lesion to be certain they remove all the malignant tissue.

However, two scientists at Washington University in St. Louis have developed technologies that promise to solve this difficult problem. Their solution, described in the July issue of ACS Nano, combines an imaging technique developed by Lihong Wang, Ph.D., the Gene K. Beare Distinguished Professor of Biomedical Engineering; and a contrast agent developed by Younan Xia, Ph.D., the James M. McKelvey Professor of Biomedical Engineering. Together, the imaging technique and contrast agent produce images of startling 3-D clarity.

Photoacoustic tomography

The imaging technique is based on the photoacoustic effect, discovered by Alexander Graham Bell 100 years ago. Bell exploited the effect in what he considered his greatest invention ever, the photophone, which converted sound to light, transmitted the light, and then converted it back to sound at the receiver. (The public preferred the telephone to the photophone because, by some facetious accounts, they didn’t believe wireless transmission was really possible.)

In Bell’s effect, the absorption of light heats a material slightly, typically by a matter of millikelvins, and the temperature rise causes thermoelastic expansion. “Much the same thing happens when you heat a balloon and it expands,” says Wang. If the light is pulsed at the right frequency, the material will expand and contract, generating a sound wave. “We detect the sound signal outside the tissue, and from there on it’s a mathematical problem,” explains Wang. “We’re essentially listening to a structure instead of looking at it. Using pure optical imaging, it is hard to look deep into tissues because light is absorbed and scattered. The useful photons run out of juice within one millimeter.”

Wang with the photoacoustic imaging system built in his lab

Photoacoustic tomography (PAT) can detect deep structures that strongly absorb light because sound scatters much less than light in tissue. “PAT improves tissue transparency by two to three orders of magnitude,” says Wang. “Moreover, it’s a lot safer than other means of deep imaging. It uses photons whose energy is only a couple of electron-volts, whereas X-rays have energies in the thousands of electron-volts. Positron emission tomography (PET) also requires high-energy photons.”

A smart contrast agent

Photoacoustic images of biological tissue can be made without the use of contrast agents, particularly if tissues are pigmented by molecules like hemoglobin or melanin. Still, photoacoustic images of melanomas are fuzzy and vague around the edges. To improve the contrast between the malignant and normal tissue, Xia loaded the malignant tissue with gold. “Gold is much better at scattering and absorbing light than biological materials,” says Xia. “One gold nanocage absorbs as much light as a million melanin molecules.”

Xia’s contrast agent consists of hollow gold cages, so tiny they can only be seen through the color they collectively lend to the liquid in which they float. By altering the size and geometry of the particles, they can be tuned to absorb or scatter light over a wide range of wavelengths. In this way, the nanoparticles behave quite differently than bulk gold.

Xia with vials of the gold nanocages developed in his lab. For the melanoma, the nanocages were tuned to near-infrared wavelengths and decorated with molecules that bind to proteins that are overexpressed on malignant melanocytes.

For photoacoustic imaging, Xia’s team tunes the nanocages to absorb strongly at 780 nanometers, a wavelength that falls within a narrow window of tissue transparency in the near-infrared. Light in this “sweet spot” can penetrate as deep as several inches into the body.

Once injected, the gold particles naturally tend to accumulate in tumors because the cells that line a tumor’s blood vessels are disorganized and leaky. But Xia has dramatically increased the uptake rate by decorating the nanoparticles with a hormone that binds to hormone receptors on the melanoma’s cells. The molecule is an alpha-melanocyte-stimulating hormone, slightly altered to make it more stable in the body. This hormone normally stimulates the production and release of the brown pigment melanin in the skin and hair.

As is true in many types of cancers, this hormone seems to stimulate the growth of cancerous cells, which produce more hormone receptors than normal cells. In experiments with mice, melanomas took up four times as many “functionalized” nanocages than nanocages coated with an inert chemical. With the contrast agent, the photoacoustic signal from the melanoma was 36-percent stronger.

But seeing is believing. Subcutaneous mouse melanomas barely visible to the unaided eye show up clearly in the photoacoustic images, their subterranean peninsulas and islands of malignancy starkly revealed.

The 3-D image of melanoma produced using the new imaging technique


About The Author

Washington University

Diana Lutz is the senior science editor at Washington University in St. Louis. Gwen Ericson is the assistant director of research news at Washington University in St. Louis. Contact the University News Service at http://news.wustl.edu.